Industry partners
What are the benefits of FinnGen and Finland for our industry partners? This autumn we took the opportunity to interview some representatives of our pharmaceutical partners who wanted to share their experiences of FinnGen.
Access to FinnGen’s unique combination of longitudinal phenotypic and genome data has attracted researchers from the pharmaceutical industry and several international companies have decided to partner with us.
Watch these short interviews to hear why!
Heiko Runz, Biogen
Caroline Fox, Merck
Mark McCarthy, Genentech
Meg Ehm, GSK